Introduction:
The Piotroski score is a numerical rating from zero to nine that evaluates a company’s financial strength. It identifies value stocks, with a score of nine indicating strong performance and zero showing weak performance across nine distinct financial criteria.
Sun Pharmaceuticals Industries Ltd:
On February 14, 2025, Sun Pharmaceutical Industries Limited opened at ₹1,747.35, reaching a high of ₹1,748.95 and a low of ₹1,685.00, down 2.54% from its previous close of ₹1,746.35. Closed at ₹1,702.00, with a market cap of ₹4,08,366.81 crore.
Sun Pharmaceuticals Industries Ltd, priced at ₹1,498.25, holds a Piotroski score of 9, reflecting strong financial fundamentals and growth potential in the pharmaceutical sector.
Sun Pharmaceuticals Industries Ltd (NSE: SUNPHARMA) is India’s largest pharmaceutical company, specializing in generics, specialty medicines, and APIs. With a strong global presence, it focuses on dermatology, oncology, and ophthalmology, making it a key player in value-driven, high-growth pharmaceutical investments.
Also Read: Energy stock jumps after signing MoU for clean energy collaboration at IEW 2025
Torrent Pharmaceuticals Ltd:
On February 14, 2025, Torrent Pharmaceuticals Limited opened at ₹3,101.90, reaching a high of ₹3,101.90 and a low of ₹2,966.05, down 2.12% from its previous close of ₹3,074.25. Closed at ₹3,008.95, with a market cap of ₹1,01,836.54 crore.
Torrent Pharmaceuticals Ltd, priced at ₹2,332.40, holds a Piotroski score of 9, showcasing robust financial health and a solid position in the pharma industry.
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) is a leading pharma company known for its expertise in cardiovascular, CNS, gastrointestinal, and pain management segments. Its strong financials, strategic acquisitions, and expanding global footprint make it a promising investment with consistent growth potential in the pharmaceutical industry.
Also Read: Jewelry stock plunges 16.49% despite record Q3 revenue of ₹2,100 Cr
Mankind Pharma Ltd:
On February 14, 2025, Mankind Pharma Limited opened at ₹2,510.00, reaching a high of ₹2,523.00 and a low of ₹2,376.35, down 4.99% from its previous close of ₹2,501.15. Closed at ₹2,376.35, with a market cap of ₹98,040.34 crore.
Mankind Pharma Ltd, priced at ₹2,073.55, holds a Piotroski score of 9, indicating strong financial fundamentals and promising long-term growth in the pharmaceutical market.
Mankind Pharma Ltd (NSE: MANKIND) is a fast-growing Indian pharmaceutical company excelling in prescription drugs, consumer healthcare, and OTC products. With a strong domestic market presence and strategic product innovation, it continues to deliver high returns, making it a valuable pharma stock to watch.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.